|Articles|June 1, 2022
Clinical ink Joins SCRS Global Impact Partner Program
Clinical ink will participate on the SCRS Global Impact Board at an executive level and work closely with SCRS’ Leadership Council.
Advertisement
The Society for Clinical Research Sites (SCRS) announced Clinical ink has joined the organization as a Global Impact Partner (GIP). As a GIP, Clinical ink will participate on the SCRS Global Impact Board at an executive level and work closely with SCRS’ Leadership Council to determine strategic initiatives for SCRS.
Read more about Clinical ink joining SCRS
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Clinical Trials in 2026: Platformization, AI Fluency, and the Redrawing of the Value Chain
2
Breaking Out of AI Pilot Mode in Clinical Development
3
ACT Brief: Community Sites Compete on Readiness, COA Licensing Bottlenecks Slow Start-Up, and AI’s Foundations in Pharmacovigilance
4
ACT Brief: Community Sites Prove Readiness, Platformization Reshapes Clinical Ops, and AI Targets Precision Care at JPM
5